The word "Say"The word "Yes"

Yellowbird Diagnostics publishes groundbreaking research in npj Precision Medicine

Congrats to Yellowbird Diagnostics, a District 3 startup, on publishing groundbreaking research in npj Precision Medicine toward creating the first objective diagnostic tool for concussion. The team identified aldehydes as an early biomarker of brain injury, detectable with their MRI contrast agent ProxyNA3, enabling injury location and severity to be seen before traditional signs appear.
Actus
Quoi de neuf?
toutes les nouvelles

1 janvier 1970